churbz: I understand the stark contrast between Ge
Post# of 30028
Posted On: 12/26/2014 2:30:30 PM
churbz: I understand the stark contrast between Gerald's comments about maybe not needing a RS and the .082 cents we are trading at now....but hold on for another 6 weeks or so. Once the market gets the whiff of potential revenue....it's appetite for our stock will become uncontrollable! I've seen it before, I've been in a stock where that exact thing happened.
Certainly we're going to start hearing of pharmas committing to use LymPro. Without any partnership or up front money, LymPro sales news will double our stock price instantly. Then, if some kind of more concrete arrangement develops with ICON where they do give us some money and we announce the up list date and spin off dates....the stock will go over .40 cents easily.
A year ago I was Gerald's biggest supporter and 3 months ago I was his biggest detractor. Today, I am again giving him the benefit of the doubt. As hard as the bashers like Biotechexpert try, this January and February will not be like times in the past where we are let down. LymPro's Launch guarantees shareholder value progress will be made in the coming 2 months.
Monday the Lympro LP002 data will be announced. We'll see what that brings. It may or may not move the stock. But at some point, we'll start hearing of Lympro work orders....and that will definitely move the stock!!
I agree with Rubenfeld...."We're there."
Certainly we're going to start hearing of pharmas committing to use LymPro. Without any partnership or up front money, LymPro sales news will double our stock price instantly. Then, if some kind of more concrete arrangement develops with ICON where they do give us some money and we announce the up list date and spin off dates....the stock will go over .40 cents easily.
A year ago I was Gerald's biggest supporter and 3 months ago I was his biggest detractor. Today, I am again giving him the benefit of the doubt. As hard as the bashers like Biotechexpert try, this January and February will not be like times in the past where we are let down. LymPro's Launch guarantees shareholder value progress will be made in the coming 2 months.
Monday the Lympro LP002 data will be announced. We'll see what that brings. It may or may not move the stock. But at some point, we'll start hearing of Lympro work orders....and that will definitely move the stock!!
I agree with Rubenfeld...."We're there."
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼